SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-18-000098
Filing Date
2018-08-02
Accepted
2018-08-02 16:17:34
Documents
3
Period of Report
2018-08-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvncq218er8-k.htm 8-K 28690
2 EXHIBIT 1 rvncq218exhibit991.htm EX-1 160981
3 newlogotaglinea01.jpg GRAPHIC 29677
  Complete submission text file 0001479290-18-000098.txt   231758
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 18988571
SIC: 2834 Pharmaceutical Preparations